Physician profile
Dina Casparro
NPI 1629417670
$852.12
in general payments reported to CMS, 2019-2025
13 companies · $39.85 in 2025
The $39.85 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.19 · 2020: $137 · 2021: $193 · 2022: $156 · 2023: $165 · 2024: $78.16 · 2025: $39.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $308.95 | 2019-2025 | Collagenase Santyl, Grafix |
| Organogenesis INC. | $268.81 | 2019-2024 | Puraply |
| Sanofi-Aventis U.S. LLC | $43.33 | 2020-2021 | |
| Xeris Pharmaceuticals, INC. | $41.71 | 2020 | |
| Dexcom, INC. | $27.54 | 2024 | Dexcom G6 Transmitter |
| Kci USA, INC. | $26.16 | 2022 | |
| Averitas Pharma INC. | $25.11 | 2023 | Qutenza |
| Bioventus LLC | $24.88 | 2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $24.58 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.93 | 2021 | |
| Corcept Therapeutics | $16.18 | 2020 | |
| Convatec INC. | $14.44 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Casparro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.